Skip to main content
logo
Nanjing Leads Biolabs Co., Ltd. (HKG:9887)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
61.00
-2.20 (-3.48%)
Sep 10, 2026, 1:14 PM HKT

Nanjing Leads Biolabs Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Market Capitalization
12,33210,143--
Market Cap Growth
-5.41%---
Enterprise Value
11,3299,977--
Last Close Price
63.2051.00--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
PS Ratio
50.1051.42--
PB Ratio
11.487.20--
P/TBV Ratio
11.507.21--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
EV/Sales Ratio
46.0250.58--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Debt / Equity Ratio
0.400.221.00-0.07
Net Debt / Equity Ratio
-0.93-1.00-1.020.30
Net Debt / EBITDA Ratio
4.177.091.081.15
Net Debt / FCF Ratio
-7.792.241.37
Asset Turnover
0.200.14--
Quick Ratio
2.083.081.350.25
Current Ratio
2.413.371.500.26
Return on Equity (ROE)
-51.55%-27.61%--
Return on Assets (ROA)
-12.87%-9.92%-30.59%-
Return on Capital Employed (ROCE)
-23.70%-15.20%-100.80%27.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Earnings Yield
-2.50%-2.32%--
FCF Yield
--1.78%--
Buyback Yield / Dilution
-25.81%-16.10%-3.56%-